180 Life Sciences (ATNF) - 2019 Q4 - Annual Report
ATNF180 Life Sciences (ATNF)2020-04-08 05:04

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38105 KBL MERGER CORP. IV (Exact name of registrant as specified in its charter) | --- | |-------------------------------------------------------- ...